JP2004509080A5 - - Google Patents

Download PDF

Info

Publication number
JP2004509080A5
JP2004509080A5 JP2002516257A JP2002516257A JP2004509080A5 JP 2004509080 A5 JP2004509080 A5 JP 2004509080A5 JP 2002516257 A JP2002516257 A JP 2002516257A JP 2002516257 A JP2002516257 A JP 2002516257A JP 2004509080 A5 JP2004509080 A5 JP 2004509080A5
Authority
JP
Japan
Prior art keywords
modafinil
degrees
liquid
reflection
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002516257A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004509080A (ja
JP4302977B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/023689 external-priority patent/WO2002010125A1/en
Publication of JP2004509080A publication Critical patent/JP2004509080A/ja
Publication of JP2004509080A5 publication Critical patent/JP2004509080A5/ja
Application granted granted Critical
Publication of JP4302977B2 publication Critical patent/JP4302977B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002516257A 2000-07-27 2001-07-27 結晶性の且つ純粋なモダフィニルおよびそれを製造する方法 Expired - Fee Related JP4302977B2 (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US22111000P 2000-07-27 2000-07-27
US22649100P 2000-08-18 2000-08-18
US22916000P 2000-08-30 2000-08-30
US23008800P 2000-09-05 2000-09-05
US25933201P 2001-01-02 2001-01-02
PCT/US2001/023689 WO2002010125A1 (en) 2000-07-27 2001-07-27 Crystalline and pure modafinil, and process of preparing the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008179304A Division JP4980309B2 (ja) 2000-07-27 2008-07-09 結晶性の且つ純粋なモダフィニルおよびそれを製造する方法

Publications (3)

Publication Number Publication Date
JP2004509080A JP2004509080A (ja) 2004-03-25
JP2004509080A5 true JP2004509080A5 (enExample) 2005-03-17
JP4302977B2 JP4302977B2 (ja) 2009-07-29

Family

ID=27539819

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002516257A Expired - Fee Related JP4302977B2 (ja) 2000-07-27 2001-07-27 結晶性の且つ純粋なモダフィニルおよびそれを製造する方法
JP2008179304A Expired - Fee Related JP4980309B2 (ja) 2000-07-27 2008-07-09 結晶性の且つ純粋なモダフィニルおよびそれを製造する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008179304A Expired - Fee Related JP4980309B2 (ja) 2000-07-27 2008-07-09 結晶性の且つ純粋なモダフィニルおよびそれを製造する方法

Country Status (24)

Country Link
US (3) US6849120B2 (enExample)
EP (3) EP1309547B1 (enExample)
JP (2) JP4302977B2 (enExample)
KR (8) KR101098749B1 (enExample)
CN (2) CN101186590A (enExample)
AT (1) ATE453618T1 (enExample)
AU (1) AU2001283008A1 (enExample)
CA (3) CA2685310C (enExample)
CY (1) CY1110234T1 (enExample)
CZ (1) CZ2003529A3 (enExample)
DE (3) DE20122504U1 (enExample)
DK (2) DK1309547T3 (enExample)
ES (2) ES2337838T3 (enExample)
HR (2) HRP20030131B1 (enExample)
HU (1) HUP0400927A3 (enExample)
IL (2) IL154122A0 (enExample)
IS (1) IS6699A (enExample)
MX (1) MXPA03000747A (enExample)
NZ (1) NZ524359A (enExample)
PL (1) PL206371B1 (enExample)
PT (2) PT1309547E (enExample)
SK (1) SK2242003A3 (enExample)
WO (1) WO2002010125A1 (enExample)
ZA (1) ZA200300672B (enExample)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101098749B1 (ko) * 2000-07-27 2011-12-23 테바 파마슈티컬 인더스트리즈 리미티드 결정질의 순수한 모다피닐 및 이의 제조 방법
BR0114814A (pt) * 2000-10-11 2005-01-25 Cephalon Inc Composições compreendendo composto de modafinila e seu uso
MXPA03003152A (es) 2000-10-11 2005-07-29 Cephalon Inc Composiciones que contienen compuestos de modafinilo.
IL163846A0 (en) 2002-03-01 2005-12-18 Univ South Florida Multiple-component solid phases containing at least one active pharmaceutical ingredient
ITMI20020991A1 (it) * 2002-05-10 2003-11-10 Dinamite Dipharma S P A In For Procedimento per la sintesi del modafinil
US6875893B2 (en) 2002-05-23 2005-04-05 Cephalon, Inc. Preparations of a sulfinyl acetamide
CN100360117C (zh) 2002-06-21 2008-01-09 转化医药公司 具有提高的溶出度的药物组合物
US20040048931A1 (en) 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
TW200413296A (en) * 2002-08-09 2004-08-01 Cephalon France Modafinil polymorphic forms
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
IL153098A0 (en) * 2002-11-26 2003-06-24 Chemagis Ltd Pharmaceutical compositions containing modafinil
FR2849029B1 (fr) * 2002-12-20 2005-03-18 Lafon Labor Procede de preparation et formes cristallines des enantiomeres optiques du modafinil.
WO2004075841A2 (en) * 2003-02-24 2004-09-10 Mallinckrodt Inc. Process for preparing benzhydrylthioacetamide
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
ATE442352T1 (de) * 2003-05-16 2009-09-15 Cephalon France Verfahren zur herstellung von modafinil
ITMI20031298A1 (it) * 2003-06-26 2004-12-27 Erregierre Spa Processo di preparazione di modafinil forma polimorfa(i).
EP1670753A4 (en) * 2003-09-04 2008-01-02 Cephalon Inc MODAFINIL COMPOSITIONS
EP1516869A1 (en) * 2003-09-19 2005-03-23 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
JP4917441B2 (ja) * 2004-02-06 2012-04-18 セフアロン・インコーポレーテツド モダフィニル組成物
CN1980888B (zh) * 2004-02-06 2011-04-13 赛福伦公司 莫达芬尼组合物
US20090018202A1 (en) * 2004-02-06 2009-01-15 Cephalon, Inc. Modafinil compositions
EP2292213A1 (en) * 2004-02-06 2011-03-09 Cephalon, Inc. Compositions comprising a polymorphic form of armodafinil
US7449481B2 (en) 2004-04-13 2008-11-11 Cephalon, Inc. Thio-substituted biaryl-methanesulfinyl derivatives
EP1586560A1 (en) 2004-04-13 2005-10-19 Cephalon, Inc. Thio-substituted arylmethanesulfinyl derivatives
US7314875B2 (en) 2004-04-13 2008-01-01 Cephalon, Inc. Tricyclic aromatic and bis-phenyl sulfinyl derivatives
US7297817B2 (en) 2004-04-13 2007-11-20 Cephalon France Thio-substituted arylmethanesulfinyl derivatives
US7119214B2 (en) 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
US20060086667A1 (en) * 2004-09-13 2006-04-27 Cephalon, Inc., U.S. Corporation Methods for the separation of enantiomeric sulfinylacetamides
BRPI0500520A (pt) * 2005-02-16 2006-09-26 Henry Jun Suzuki uso de agentes flavorizantes aromáticos de alto ponto de fusão como agentes solubilizantes ou inibidores de cristalização em composições farmacêuticas
BRPI0501120A (pt) * 2005-02-18 2006-10-03 Henry Jun Suzuki composições farmacêuticas orais e parenterais contendo altas concentrações de agentes solubilizantes aromáticos
CN100393699C (zh) * 2005-03-10 2008-06-11 浙江工业大学 2-(二苯基甲基亚硫酰基)乙酰胺的合成方法
JP2009518398A (ja) * 2005-12-09 2009-05-07 マリンクロッド・インコーポレイテッド モダフィニルおよびその類似体の製造方法
MX2007012605A (es) * 2006-02-21 2008-01-11 Teva Pharma Formas cristalinas novedosas de armodafinil y preparacion de ellas.
MX2009000391A (es) * 2006-07-12 2009-06-30 Elan Pharma Int Ltd Formulación de modafinilo en forma de nano-partículas.
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
WO2008149141A2 (en) * 2007-06-04 2008-12-11 Generics [Uk] Limited Novel process
US7960586B2 (en) * 2007-08-16 2011-06-14 Teva Pharmaceutical Industries Ltd. Purification of armodafinil
FR2923482B1 (fr) * 2007-11-09 2010-01-29 Servier Lab Nouvelle forme cristalline vi de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
WO2009045488A2 (en) * 2007-10-02 2009-04-09 Teva Pharmaceutical Industries Ltd. Novel crystalline forms of armodafinil and preparation thereof
US20100036164A1 (en) * 2008-08-06 2010-02-11 Srinivas Areveli Preparation of armodafinil form i
US8551887B2 (en) 2009-12-22 2013-10-08 Air Products And Chemicals, Inc. Method for chemical mechanical planarization of a copper-containing substrate
CN102070498A (zh) * 2011-01-12 2011-05-25 华东师范大学 一种亚砜的制备方法
CN102746202B (zh) * 2012-07-04 2013-12-18 广州市博兴化工科技有限公司 一种含有甲基亚砜结构的丙烯酸酯化合物及其制备方法和应用
KR102495018B1 (ko) 2013-11-15 2023-02-06 아케비아 테라퓨틱스 인코포레이티드 {[5-(3-클로로페닐)-3-하이드록시피리딘-2-카보닐]아미노}아세트산의 고체형, 이의 조성물 및 용도
CN104045588A (zh) * 2014-06-11 2014-09-17 江苏斯威森生物医药工程研究中心有限公司 一种2-(4,4’-二卤-二苯基甲基亚磺酰)乙酰胺的合成方法
US9616068B2 (en) 2014-10-27 2017-04-11 Pohela LLC Animal training using cognitive enhancement
KR102393940B1 (ko) 2020-11-12 2022-05-09 주식회사 에스코넥 토션 타입 힌지 스프링
KR102369302B1 (ko) 2020-11-12 2022-03-02 주식회사 에스코넥 압축 타입 힌지 스프링
KR102369295B1 (ko) 2020-11-12 2022-03-02 주식회사 에스코넥 벤딩 타입 힌지 스프링

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127722A (en) 1975-10-02 1978-11-28 Laboratoire L. Lafon Benzhydrylsulphinyl derivatives
GB1584462A (en) * 1977-03-31 1981-02-11 Lafon Labor N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them
FR2593809B1 (fr) 1986-01-31 1988-07-22 Lafon Labor Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique
FR2606015B1 (fr) 1986-08-13 1989-05-19 Lafon Labor Derives du benzhydrylthiomethane, leurs procedes de preparation et leurs applications en therapeutique
FR2611709B1 (fr) 1987-02-26 1989-06-09 Lafon Labor 2-(benzhydrylsulfonyl)acetamide, son procede de preparation et son application en therapeutique
US5843347A (en) 1993-03-23 1998-12-01 Laboratoire L. Lafon Extrusion and freeze-drying method for preparing particles containing an active ingredient
FR2707637B1 (fr) 1993-06-30 1995-10-06 Lafon Labor Nouveaux dérivés d'acétamide, leur procédé de préparation et leur utilisation en thérapeutique.
US5618845A (en) 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
FR2771004B1 (fr) 1997-11-19 2000-02-18 Inst Curie Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse
US6346548B1 (en) 1999-08-16 2002-02-12 Cephalon, Inc. Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
US6455588B1 (en) 1999-08-20 2002-09-24 Cephalon, Inc. Compositions including modafinil for treatment of eating disorders and for appetite stimulation
CN1249932A (zh) * 1999-09-29 2000-04-12 付俊昌 一种莫达芬尼及其光学对映体l及d异构体的新用途
FR2804322B1 (fr) 2000-01-31 2002-04-19 Lafon Labor Utilisation du modafinil pour la fabrication d'un medicament destine a corriger les troubles de la vigilance associes aux myopathies
KR101098749B1 (ko) * 2000-07-27 2011-12-23 테바 파마슈티컬 인더스트리즈 리미티드 결정질의 순수한 모다피닐 및 이의 제조 방법
US6919378B2 (en) 2000-10-11 2005-07-19 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
IL143106A (en) * 2001-05-13 2005-11-20 Chemagis Ltd Process for the preparation of diphenylmethylthioacetamide
KR100911779B1 (ko) 2001-05-25 2009-08-12 세파론, 인코포레이티드 모다피닐을 포함하는 고형 제약 제제
ITMI20020991A1 (it) 2002-05-10 2003-11-10 Dinamite Dipharma S P A In For Procedimento per la sintesi del modafinil
US6875893B2 (en) 2002-05-23 2005-04-05 Cephalon, Inc. Preparations of a sulfinyl acetamide
US7229644B2 (en) 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
AU2003249105A1 (en) 2002-07-08 2004-01-23 Ranbaxy Laboratories Limited Processes for the preparation of oral dosage formulations of modafinil
US20040048931A1 (en) 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
US6992219B2 (en) 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
US20040116532A1 (en) 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
CA2409429A1 (en) * 2002-10-17 2004-04-17 Bayer Inc. Hydrogenated nitrile rubber composites with improved proccesability
IL153098A0 (en) 2002-11-26 2003-06-24 Chemagis Ltd Pharmaceutical compositions containing modafinil
CA2514900A1 (en) 2003-01-31 2004-09-10 Alembic Limited Process for the preparation of 2-[(diphenylmethyl) thio] acetamide
WO2004075841A2 (en) 2003-02-24 2004-09-10 Mallinckrodt Inc. Process for preparing benzhydrylthioacetamide
CA2420180A1 (en) 2003-02-28 2004-08-28 Bernard Charles Sherman Tablets comprising modafinil
AR045423A1 (es) 2003-05-13 2005-10-26 Cephalon Inc Combinaciones de analiticos y antidepresivos
US20040229941A1 (en) 2003-05-13 2004-11-18 Cephalon, Inc. Analeptic and antidepressant combinations
AR045314A1 (es) 2003-05-13 2005-10-26 Cephalon Inc Composiciones farmaceuticas de analepticos y antidepresivos
US20040229943A1 (en) 2003-05-16 2004-11-18 Cephalon Inc Analeptic and drug combinations
ITMI20031298A1 (it) 2003-06-26 2004-12-27 Erregierre Spa Processo di preparazione di modafinil forma polimorfa(i).

Similar Documents

Publication Publication Date Title
JP2004509080A5 (enExample)
CA2416792A1 (en) Crystalline and pure modafinil, and process of preparing the same
JP2005504086A5 (enExample)
EP2471795A1 (en) Method for preparing prasugrel
ES2206617T3 (es) Nuevo procedimiento de fabricacion.
AU748177B2 (en) Crystalline forms of osanetant
AU764594B2 (en) Crystal forms of 3-(2,4-dichlorobenzyl)-2-methyl-N- (pentylsulfonyl)-3H-benzimidazole-5-carboxamide
JP2019055989A (ja) カバジタキセルの結晶性無水和物形態、その調製方法ならびにその医薬組成物
BE897617A (fr) Thioesters d'acide acetylsalicylique procede pour les preparer et compositions pharmaceutiques qui en renferment
WO2000078729A1 (en) Crystalline forms of lansoprazole
ES2443523T3 (es) Procedimiento para la preparación de hidrocloruro de lercanidipina amorfo
JP3188476B2 (ja) 両性イオン形トロバフロキサシン
KR102709537B1 (ko) 초순수 트레프로스티닐의 효율적인 결정화 방법 및 그로부터 제조된 결정
WO2005023769A1 (en) Process for the preparation of amlodipine salts
WO2006035291A1 (en) Crystalline forms of cefdinir potassium
WO2007020009A1 (en) New crystalline form of perindopril erbumine
ES2275110T3 (es) Procedimiento para la preparacion de zaleplon.
JP3089373B2 (ja) 2−メルカプト−フェノチアジンの製造方法
CN106632347B (zh) 一种吡咯并吡嗪化合物及其盐的制备方法
JP2002532510A (ja) クラリスロマイシンの製造に於けるマクロライド中間体
CN113024433A (zh) 一种氨磺必利亚砜杂质的制备方法
JP3256376B2 (ja) トシル酸スプラタストの結晶およびその製造方法
JPH0359063B2 (enExample)
EP1511750A1 (en) Process for the preparation of famciclovir
WO1995035292A1 (en) Antiviral agent containing benzodithiin derivative as active ingredient